Question

A 52-year-old with stage 3b CKD (eGFR 38) and albuminuria (ACR 300 mg/g) with type 2 diabetes is on maximally tolerated ACE inhibitor. Next evidence-based therapy to slow CKD progression?

Accepted Answer

Start an SGLT2 inhibitor

Answer

Add a thiazolidinedione

Answer

Switch ACE inhibitor to ARB

Answer

Start calcium channel blocker

Answer

Start fenofibrate

Practice question

A 52-year-old with stage 3b CKD (eGFR 38) and albuminuria (ACR 300 mg/g) with type 2 diabetes is on maximally tolerated ACE inhibitor. Next evidence-based therapy to slow CKD progression?